These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18698224

  • 1. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C.
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [Abstract] [Full Text] [Related]

  • 2. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS.
    Am J Kidney Dis; 2002 Jul; 40(1):68-75. PubMed ID: 12087563
    [Abstract] [Full Text] [Related]

  • 3. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P.
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 is a predictor of mortality in stable hemodialysis patients.
    Hasuike Y, Nonoguchi H, Ito K, Naka M, Kitamura R, Nanami M, Tokuyama M, Kida A, Otaki Y, Kuragano T, Nakanishi T.
    Am J Nephrol; 2009 May; 30(4):389-98. PubMed ID: 19690405
    [Abstract] [Full Text] [Related]

  • 5. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.
    Ren Fail; 2008 May; 30(6):617-23. PubMed ID: 18661412
    [Abstract] [Full Text] [Related]

  • 6. Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients.
    Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, Tripepi G, Benedetto FA, Leonardis D, Fatuzzo P, Rapisarda F, Zoccali C.
    Nephron Clin Pract; 2010 May; 114(1):c74-80. PubMed ID: 19851079
    [Abstract] [Full Text] [Related]

  • 7. A new systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts overall and cardiovascular mortality in hemodialysis patients.
    Chen SC, Chang JM, Tsai JC, Hsu PC, Lin TH, Su HM, Voon WC, Hwang SJ, Chen HC.
    Hypertens Res; 2010 May; 33(5):492-8. PubMed ID: 20203683
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
    Nishimura M, Hashimoto T, Kobayashi H, Fukukda T, Okino K, Yamamoto N, Nakamura N, Yoshikawa T, Takahashi H, Ono T.
    J Nephrol; 2003 May; 16(5):641-9. PubMed ID: 14733409
    [Abstract] [Full Text] [Related]

  • 9. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [Abstract] [Full Text] [Related]

  • 10. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias.
    Burton JO, Korsheed S, Grundy BJ, McIntyre CW.
    Ren Fail; 2008 Sep; 30(7):701-9. PubMed ID: 18704819
    [Abstract] [Full Text] [Related]

  • 11. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G, Griuncelli M, Loridon C, Benmaadi A, Illouz E.
    Cardiology; 2009 Sep; 114(2):142-9. PubMed ID: 19521079
    [Abstract] [Full Text] [Related]

  • 12. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
    Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, Liu L, Huang JY, Huang YL.
    J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
    [Abstract] [Full Text] [Related]

  • 13. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients.
    Yang FL, Lee RP, Wang CH, Fang TC, Hsu BG.
    Ren Fail; 2007 Aug; 29(8):997-1001. PubMed ID: 18067047
    [Abstract] [Full Text] [Related]

  • 14. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW, Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group.
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.
    Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P.
    Am Heart J; 2005 Jul; 150(1):137-43. PubMed ID: 16084160
    [Abstract] [Full Text] [Related]

  • 16. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimbürger O, Bárány P, Suliman ME, Lindholm B, Stenvinkel P, Qureshi AR.
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A, Del Vecchio L, Del Rosso G, Malandra R, Gruppo di Studio Dell’Ipertensione Arteriosa, Società Italiana di Nefrologia.
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [Abstract] [Full Text] [Related]

  • 18. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B, Petrović D, Obrenović R.
    Med Pregl; 2007 Mar; 60 Suppl 2():155-9. PubMed ID: 18928184
    [Abstract] [Full Text] [Related]

  • 19. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J, Guo Q, Qureshi AR, Anderstam B, Eriksson M, Heimbürger O, Bárány P, Stenvinkel P, Lindholm B.
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [Abstract] [Full Text] [Related]

  • 20. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A, Mulè G, Vadalà A, Vaccaro F, Guarneri M, Arsena R, Briolotta C, Cerasola G, Cottone S.
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.